US FDA News: FDA Approves First Drug to Treat Rare Metabolic Disorder

Today, the FDA approved the first treatment for primary hyperoxaluria type 1 (PH1), a rare genetic disorder which causes recurrent kidney stones and loss of kidney function.
Read more: FDA Approves First Drug to Treat Rare Metabolic Disorder